Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

771 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current view from Alzheimer disease to type 2 diabetes mellitus.
Rasool M, Malik A, Qazi AM, Sheikh IA, Manan A, Shaheen S, Qazi MH, Chaudhary AG, Abuzenadah AM, Asif M, Alqahtani MH, Iqbal Z, Shaik MM, Gan SH, Kamal MA. Rasool M, et al. Among authors: kamal ma. CNS Neurol Disord Drug Targets. 2014 Apr;13(3):533-42. doi: 10.2174/18715273113126660167. CNS Neurol Disord Drug Targets. 2014. PMID: 24059295 Review.
Current acetylcholinesterase-inhibitors: a neuroinformatics perspective.
Shaikh S, Verma A, Siddiqui S, Ahmad SS, Rizvi SM, Shakil S, Biswas D, Singh D, Siddiqui MH, Shakil S, Tabrez S, Kamal MA. Shaikh S, et al. Among authors: kamal ma. CNS Neurol Disord Drug Targets. 2014 Apr;13(3):391-401. doi: 10.2174/18715273113126660166. CNS Neurol Disord Drug Targets. 2014. PMID: 24059296 Review.
Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a neuroinformatics study.
Shaikh S, Ahmad SS, Ansari MA, Shakil S, Rizvi SM, Shakil S, Tabrez S, Akhtar S, Kamal MA. Shaikh S, et al. Among authors: kamal ma. CNS Neurol Disord Drug Targets. 2014 Apr;13(3):452-9. doi: 10.2174/18715273113126660162. CNS Neurol Disord Drug Targets. 2014. PMID: 24059300
Alzheimer's and type 2 diabetes treatment via common enzyme targeting.
Jabir NR, Kamal MA, Abuzenadah AM, Gan SH, Alama MN, Baeesa SS, Tabrez S. Jabir NR, et al. Among authors: kamal ma. CNS Neurol Disord Drug Targets. 2014 Mar;13(2):299-304. doi: 10.2174/18715273113126660145. CNS Neurol Disord Drug Targets. 2014. PMID: 24059315 Review.
Genomic linkage between Alzheimer's disease and type 2 diabetes.
Nedjadi T, Haque A, Alam Q, Gan SH, Chaudhary AG, Abuzenadah AM, Damanhouri GA, Kamal MA. Nedjadi T, et al. Among authors: kamal ma. CNS Neurol Disord Drug Targets. 2014 Mar;13(2):203-12. doi: 10.2174/18715273113126660140. CNS Neurol Disord Drug Targets. 2014. PMID: 24059319 Review.
771 results